![Vincent Rajkumar: Medicare has negotiated lower prices for prescription drugs](https://oncodaily.com/pub/uploads/2024/08/MYis_acO_400x400-e1723895508217.jpg)
Vincent Rajkumar: Medicare has negotiated lower prices for prescription drugs
Vincent Rajkumar shared a post on X:
“Breaking: Medicare for the first time in history, has negotiated lower prices for prescription drugs. For the 10 drugs chosen, Medicare will save >$6 billion a year, because of 38 to 79 percent discounts off of list prices.
These are the 10 drugs that will see price reductions starting 2026. I have long supported Medicare negotiation for prescription drugs. I am glad it is finally happening.
Here are the results of the negotiation for the top 10 drugs
It’s amazing that in 2024 we are in a position where negotiations are needed for price of insulin.
This is the start of a major change in prescription drug policy enacted as part of the Inflation Reduction Act. Next year Medicare can negotiate for 15 additional drugs. And so on. See below.
Read further.
Source: Vincent Rajkumar/X
Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee.
His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.